These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22202303)

  • 1. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
    Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective feasibility study to evaluate neoadjuvant-synchronous S-1 + RT for locally advanced rectal cancer: a multicenter phase II trial (UMIN ID: 03396).
    Inomata M; Akagi T; Nakajima K; Etoh T; Shiraishi N; Tahara K; Matsumoto T; Kinoshita T; Fujii K; Shiromizu A; Kubo N; Kitano S
    Jpn J Clin Oncol; 2013 Mar; 43(3):321-3. PubMed ID: 23275647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
    Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of locally advanced rectal carcinoma effectively treated with preoperative chemoradiotherapy].
    Kitani K; Okajima K; Kimura H; Ikeda M; Inoue K; Iwama M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ishikawa K; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2635-7. PubMed ID: 21224663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
    Tanishima H; Horiuchi T; Tamagawa K; Tsujimoto T; Miyagawa Y; Ishida K; Uemura R; Hama T; Sakaguchi S; Shono Y; Tsubakihara H; Tabuse K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1397-400. PubMed ID: 20647736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A resected case of pathologically complete response of a pelvic recurrence from rectal cancer after chemoradiotherapy with S-1].
    Nakano D; Matsumoto H; Yamaguchi T; Iwasaki Y; Ohashi M; Iwanaga T; Takahashi K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2137-9. PubMed ID: 20037348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy].
    Okazaki S; Ohtsukasa S; Nakajima Y; Kamiya A; Nagano H; Takamatsu S; Kawachi Y; Maruyama H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2256-8. PubMed ID: 22202347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Our experiences of preoperative chemo-radiotherapy for T4 primary rectal cancer].
    Sato H; Maeda K; Hanai T; Koide Y; Aoyama H; Matsuoka H; Katsuno H; Funahashi M; Agata T; Noro T; Honda K; Shiota M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2018-20. PubMed ID: 19106509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case Report of a Pathological Complete Response of Rectal Cancer to Preoperative Chemoradiotherapy with Tegafur].
    Morikawa T; Teraishi F; Shima Y; Iwata J
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):381-4. PubMed ID: 27067861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan and S-1 neoadjuvant chemoradiation therapy in patients with advanced rectal cancer.
    Sato T; Kokuba Y; Koizumi W; Ozawa H; Nakamura T; Ihara A; Ootani Y; Watanabe M
    Hepatogastroenterology; 2007; 54(77):1391-3. PubMed ID: 17708261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Cancer Genomics Proteomics; 2011; 8(2):87-92. PubMed ID: 21471518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.
    Morimoto S; Shimada M; Kurita N; Sato H; Iwata T; Nishioka M; Yoshikawa K; Miyatani T; Kashihara H; Takasu C; Ikushima H
    Hepatogastroenterology; 2012; 59(117):1428-32. PubMed ID: 22155856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative chemoradiotherapy for resectable lower rectal cancer].
    Takase S; Kamigaki T; Yamashita K; Nakamura T; Nishimura H; Sasaki R
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2006-8. PubMed ID: 20037306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our experiences of preoperative chemoradiotherapy for rectal cancer with invasion to adjacent organs].
    Sato H; Maeda K; Hanai T; Koide Y; Matsuoka H; Katsuno H; Agata T; Noro T; Honda K; Shiota M; Ozeki S; Hatta K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2143-5. PubMed ID: 20037350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
    Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
    Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01).
    Kim DY; Kim TH; Jung KH; Chang HJ; Lim SB; Choi HS; Jeong SY; Nam TK; Ryu SY; Lee DS; Choi SI; Kang JH; Yoon SC
    Dis Colon Rectum; 2006 Nov; 49(11):1684-91. PubMed ID: 16988851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.